5-methylurapidil

Known as: 5-methyl-urapidil 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
INTRODUCTION Venous leak evaluation remains a challenge in many ED patients. Adequate anatomical evaluation may help with… (More)
Is this relevant?
2006
2006
OBJECTIVE To compare the in vitro human ureteric muscle response to calcium-channel and alpha-adrenoceptor antagonists, to… (More)
Is this relevant?
2004
2004
OBJECTIVE To investigate the involvement of alpha1-adrenoceptors in the sympathetic regulation of glucose uptake in human… (More)
Is this relevant?
2002
2002
BACKGROUND Coronary flow reserve (CFR) is not normalized shortly after coronary stenting. We hypothesized that alpha-adrenergic… (More)
Is this relevant?
2002
2002
Background—Coronary flow reserve (CFR) is not normalized shortly after coronary stenting. We hypothesized that -adrenergic… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2000
2000
BACKGROUND We investigated plasma endothelin (ET) levels in patients with congestive heart failure (CHF) during treatment for… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
1997
1997
PURPOSE To evaluate the effects of 5-methylurapidil (5-MU) on intraocular pressure (IOP) and aqueous humor dynamics in female… (More)
Is this relevant?
1990
1990
1. The effects of the 5-HT1a receptor agonists 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and 5-methylurapidil (5-MU) on… (More)
Is this relevant?
1988
1988
The affinity of 5-methyl-urapidil for alpha 1-adrenoceptors was determined from the inhibition of [3H]prazosin binding on… (More)
Is this relevant?
1987
1987
The mechanism responsible for the antihypertensive effect of urapidil is not yet completely understood. Its vasodilator action… (More)
  • figure 1
  • table 1
  • table 2
Is this relevant?